Objectives: The aim of this study was: (i) to study the prevalence of triazole-resistant Aspergillus fumigatus isolates in the Netherlands; and (ii) to design rapid real-time PCR methods to identify such isolates.
Introduction
Considerable progress has been made in unravelling the molecular mechanisms behind triazole resistance in Aspergillus fumigatus. The cyp51A gene product, encoding the 14a sterol demethylase, has been firmly established as the target for triazole-based antifungals. 1 Up to the end of 2008, no less than 13 mutations that are causative of a resistance phenotype had been identified at six amino acid positions in this gene. 2 -7 These positions involve Asn22, Gly54, Leu98, Gly138, Met220 and Gly448. However, mutations at positions Asn22 and Gly448 were reported only after laboratory-induced resistance by random mutagenesis and were not found in clinical isolates. It should be noted that the L98H mutation only leads to triazole resistance in combination with a duplication of a 34 bp DNA fragment in the promoter region of the cyp51A gene. 4 These combined changes (L98H þTR) lead to a multi-triazole resistance phenotype. Different mutations may lead to different susceptibility profiles. Therefore, rapid identification of triazole-resistant isolates as well as identification of the underlying mutations are important for optimal patient management and may be valuable in epidemiological surveys. Here, we report the application of a new mixed-format real-time PCR assay for the analysis of mutations at positions Gly54, Leu98, Gly138 and Met220 of the cyp51A gene of A. fumigatus. This new assay was used to determine the prevalence of triazole resistance mutations among clinical A. fumigatus isolates from the Netherlands.
Materials and methods

Reference samples
A. fumigatus isolates containing a variety of mutations at codons 54 or 220 of the cyp51A gene were provided by Dr E. Mellado 
Clinical isolates
The A. fumigatus isolates were collected during a 6 month period in 2005 from non-selected patient populations in 14 major hospitals throughout the Netherlands. Initially, 242 isolates were collected, but 27 isolates proved to be non-A. fumigatus. If more than one isolate was provided per patient, only the first isolate was used for analysis. In total, 209 isolates were included in this study. Most isolates were from respiratory specimens, and a few were from cerebral and sinus aspirates. Identification was done by macroscopic and microscopic growth characteristics, and growth at 488C.
Principle of the mixed-format real-time PCR assay
The principle of the new assay format is illustrated in Figure 1 . Hybridization of the single-stranded DNA (ssDNA) detection probe to the ssDNA target leads to a partially double-stranded DNA (dsDNA) hybrid molecule. Upon embedding in the dsDNA molecule, the fluorescent Resolight dye is excited by the blue light (480 nm) and emits a bright green light (530 nm). The energy from the emitted green light (530 nm) is transferred, by a process known as fluorescence resonance energy transfer (FRET), to a fluorescent reporter label that emits a red light (640 nm) (Figure 1a ). When the temperature is increased, the partially dsDNA hybrid molecule is denatured, leading to a loss of signal at 640 nm, allowing the generation of so-called 'melting peaks'. The probes are designed so that a perfect hybrid will yield a melting peak at 658C. Any mismatch to the probe will become apparent by a melting peak at a lower temperature. Amplification reactions are performed in an asymmetrical fashion. This generates a mixture of dsDNA and ssDNA target molecules. The dsDNA targets are detected through the presence of the Resolight dye that is also detected at 640 nm. Their presence is verified by the formation of a melting peak at 858C (temperature may vary for amplicons of different sizes and/or different GC content). The extent of asymmetry during PCR directly influences the ratio between the ssDNA and dsDNA targets. Optimal conditions involve primer ratios of 1:1.5 to 1:5. If the amount of asymmetry is too high, poor amplification is achieved (leading to low overall signals); if the amount of asymmetry is too low, the amount of ssDNA targets is too low (leading to low probespecific signals).
Real-time mutation detection
DNA was isolated from sporulating cultures grown for 48 h on Sabouraud glucose agar using established procedures. Amplifications were performed on a LightCycler 480 (Roche Diagnostics, Almere, The Netherlands) in a final volume of 10 mL containing 1 ng of fungal DNA, amplification primers (Eurogentec, Seraing, Belgium) and mutation detection probe (TIB Molbiol, Berlin, Germany) (primer and probe concentrations according to Table 1 ), 1 U of FastStart Taq DNA polymerase (Roche Diagnostics), 0.2 mM dNTPs and 1Â Resolight dye (Roche Diagnostics) in 1Â reaction buffer containing 2 mM MgCl 2 . The cycling parameters were as follows; after an initial denaturation step for 10 min at 958C, 45 amplification cycles of 2 s of denaturation at 958C, 5 s of annealing at 608C and 20 s of extension at 728C were applied. The melting protocol consisted of denaturation at 958C for 2 s and 458C for 30 s, after which the temperature was increased to 958C, with 10 acquisitions per 8C under continuous monitoring of the fluorescence at 640 nm.
Detection of the 34 bp duplication in the cyp51A promoter region
Amplifications were performed in a reaction volume of 10 mL using 1 ng of genomic DNA, 0.5 mM of amplification primers 51APrF and 51APrR, 0.5 U of FastStart Taq DNA polymerase (Roche Diagnostics), 0.2 mM dNTPs, 1Â Resolight dye and 2.5 mM MgCl 2 in 1Â reaction buffer. The amplification parameters were denaturation for 10 min at 958C, followed by 35 cycles of 958C for 1 s, 608C for 2 s and 728C for 5 s. Following amplification, melting curves were recorded by increasing the temperature up to 958C, with five acquisitions per 8C.
MIC determination
MICs of itraconazole (Janssen Research Foundation, Beerse, Belgium), voriconazole (Pfizer Central Research, Sandwich, Kent, UK), posaconazole (Schering-Plough Corp., Kenilworth, NJ, USA) and isavuconazole (Basilea Pharmaceutica International Ltd, Basel, Switzerland) were determined by broth microdilution according to CLSI M38-A2. 8 
Results
Real-time mutation detection
In Figure 1(b and c) , typical results are shown for position Leu98 using either a wild-type probe or L98H-specific probe, respectively. In Figure 1(d and e) , results are shown using a wild-type probe for Gly54 and Met220, respectively. In both examples, it is clearly visible that different mutations lead to the formation of different melting profiles, allowing the use of a single probe at each position for the discrimination between wild-type products and products containing one of several different mutations. Additional low-intensity peaks are observed in the range of 75 -808C. These peaks strongly correlate to the concentration of the mutation detection probe (Figure 1f ) and may be the result of local secondary structures.
Real-time detection of the cyp51A promoter polymorphism
In Figure 1 (g), typical amplification curves and melting peaks are shown for the cyp51A promoter region. Presence of the 34 bp duplication in the cyp51A promoter will lead to the generation of a PCR product that is easily distinguished from the wild-type product by its melting peak at an increased temperature (888C versus 868C, respectively). Control amplification reactions without template DNA showed no melting peaks (data not shown).
Prevalence of triazole resistance mutations among clinical isolates from the Netherlands
Four out of 209 isolates (1.9%) were resistant to itraconazole (MIC! 16 mg/L) and cross-resistant to voriconazole (MIC! 8 mg/L), posaconazole (two isolates had an MIC of .8 mg/L and two isolates had an MIC of 0.5 mg/L) and isavuconazole (MIC !4 mg/L). All four isolates contained the L98H þTR mutations. Neither of these two mutations nor a mutation at any of the other interrogated amino acid positions was found in the 205 phenotypically triazole-susceptible isolates.
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Discussion
We report the use of a novel mixed-format real-time mutation detection format to identify point mutations known to be involved in triazole resistance in A. fumigatus. Identification of resistance mutations in the cyp51A gene was typically performed using DNA sequence analysis. 2,4,9 Since these assay formats require multiple post-PCR steps (involving massive amounts of PCR products), they are also more prone to contamination and, thus, require rigorous protocols and dedicated pre-and post-PCR facilities. Any additional post-PCR step also increases the workload, and is associated with higher personnel costs and increased turnaround time. The switch to closed-tube realtime PCR formats may overcome most of these disadvantages.
Unlike most other real-time PCR formats, the new assay format has a built-in internal amplification control. Theoretically, with certain real-time formats, the presence of polymorphisms underneath a specific probe could lead to an unintended loss of signal (e.g. using TaqMan/hydrolysis probes or Molecular Beacons). Such a result could also be the consequence of probe failure or a lack of amplification (e.g. due to nucleotide polymorphisms in the primer region or by the presence of inhibitors of the PCR process). Without additional tests, it is impossible to distinguish between these options. In the mixed-format assay described here, the additional amplicon-specific melting peak (at 858C) confirms successful amplification in a probe-independent manner and, thus, serves as a convenient internal amplification control.
In this study, 4 out of 209 clinical A. fumigatus isolates were found that contained the L98H þTR mutations. Phenotypic resistance testing led to the identification of the same four isolates as being resistant to multiple triazoles. Thus, the results of the new real-time PCR assay format were 100% concordant with phenotypic resistance determinations. Whereas other mutations leading to triazole resistance may be an emerging problem during triazole therapy by induction, 10 none of these mutations was found in this collection from the Netherlands. Our novel approach can easily be expanded to include additional mutations leading to triazole resistance in A. fumigatus. It is now believed that isolates containing the L98HþTR mutations are acquired from the environment. 11 Consequently, our results provide an estimate of the a priori risk of acquiring a multi-triazole-resistant isolate in the Netherlands of ,2%. 
